Skip to main content
. Author manuscript; available in PMC: 2024 Jun 29.
Published in final edited form as: N Engl J Med. 2023 May 18;388(26):2434–2443. doi: 10.1056/NEJMoa2215201

Figure 1. Assessment of Eligibility for Case Patients and Control Patients.

Figure 1.

Among 350 of 4494 patients with a new or refill order for human immunodeficiency virus (HIV) preexposure prophylaxis who were excluded because of an mpox diagnosis, 2 patients had a prescription for tecovirimat from 14 days before the index event through November 19, 2022. EHR denotes electronic health record, and MPXV mpox virus.